MANIFESTING CARRIERS OF DUCHENNE OR BECKER MUSCULAR DYSTROPHY

Similar documents
Muscular Dystrophy. By. Tina Strauss

Duchenne muscular dystrophy (DMD)

DIAGNOSING CHILDHOOD MUSCULAR DYSTROPHIES

Genetic Testing for Duchenne and Becker Muscular Dystrophy

Duchenne muscular dystrophy

MUSCULAR DYSTROPHY GENETICS AND TESTING

Rigid spine syndrome (RSS) (Congenital muscular dystrophy with rigidity of the spine, including RSMD1)

Limb girdle muscular dystrophies (LGMDs)

Central core disease

Oculopharyngeal muscular dystrophy (OPMD)

Carrier detection tests and prenatal diagnosis

1: Motor neurone disease (MND)

Neuromuscular diseases

Pediatric Neuromuscular Disorders: Transitions to Adult Providers

Muscle Physiology and the. Pathology of Muscular Dystrophy

Muscular Dystrophy: Stem Cell Therapy

INFORMED CONSENT INFORMED CONSENT FOR PARTICIPATION IN A HEALTH AND FITNESS TRAINING PROGRAM

FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies

Facioscapulohumeral Muscular Dystrophy

Becker Muscular Dystrophy

CHAPTER 15 THE CHROMOSOMAL BASIS OF INHERITANCE. Section B: Sex Chromosomes

CorCap Cardiac Support Device Patient Information Booklet

This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive.

What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives

Life Insurance. What you need to know about. Mucopolysaccharide and related diseases including Fabry disease

LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD

Neuromuscular disorders Development of consensus for diagnosis and standards of care. Thomas Sejersen, Pediatric neurology

Minicore (multicore) myopathy

Rheumatoid Arthritis

Muscular dystrophy clinical manifestations: progressive proximal extremity weakness respiratory muscle weakness cardiomyopathy

Facts About Peripheral Arterial Disease (P.A.D.)

1 ALPHA-1. The Liver and Alpha-1 Antitrypsin Deficiency (Alpha-1) FOUNDATION FOUNDATION. A patient s guide to Alpha-1 liver disease

LQTS: Long QT Syndrome. Inherited Heart Disease Clinic

Cerebral Palsy , The Patient Education Institute, Inc. nr Last reviewed: 06/17/2014 1

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

Cerebral Palsy. In order to function, the brain needs a continuous supply of oxygen.

Facts About Rare Muscular Dystrophies

Respiration occurs in the mitochondria in cells.

Radical Hysterectomy and Pelvic Lymph Node Dissection

YOUR GUIDE TO TOTAL HIP REPLACEMENT

Markham Stouffville Hospital

Fact Sheet 14 EPIGENETICS

Symptoms of Hodgkin lymphoma

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1

Breast cancer and genetics

Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2

PARKINSON S DISEASE INTRODUCTION. Parkinson s disease is defined as a disease of the nervous system that affects voluntary movement.

Insurance. Chapter 7. Introduction

The Developing Person Through the Life Span 8e by Kathleen Stassen Berger

Management in the pre-hospital setting

CHROMOSOMES AND INHERITANCE

Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes

Mendelian inheritance and the

Gene Therapy and Genetic Counseling. Chapter 20

Preimplantation Genetic Diagnosis (PGD) in Western Australia

Usher Syndrome Genetics

BRCA1 & BRCA2 GeneHealth UK

Myotonic Dystrophy: Making an Informed Choice About Genetic Testing

SCRIPT NUMBER 122 VARICOSE VEINS - 2 (TWO SPEAKERS)

Parkinson's disease. Definition. Symptoms

Facioscapulohumeral Muscular Dystrophy: Making an Informed Choice About Genetic Testing

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

Obstetrical Ultrasound and Prenatal Diagnostic Center

INTRODUCTION Thrombophilia deep vein thrombosis DVT pulmonary embolism PE inherited thrombophilia

X Linked Inheritance

Genetic Mutations. Indicator 4.8: Compare the consequences of mutations in body cells with those in gametes.

WHAT DOES DYSMETABOLIC SYNDROME MEAN?

KNEE ARTHROSCOPY. Dr C.S. Waller. Orthopaedic Surgeon

The Liver and Alpha-1. Antitrypsin Deficiency (Alpha-1) 1 ALPHA-1 FOUNDATION

1 Mutation and Genetic Change

Multiple System Atrophy guide (

U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet

Muscular Dystrophy and Multiple Sclerosis. ultimately lead to the crippling of the muscular system, there are many differences between these

Genetic Testing in Research & Healthcare

Implementing Medical Checkups to Prevent. Sports-Related Injuries and Disorders

Fitness Training A Sensible Guide to Preparing for Selection in the Gurkhas

Asbestos Related Diseases. Asbestosis Mesothelioma Lung Cancer Pleural Disease. connecting raising awareness supporting advocating

Asbestos Related Diseases

Learn the steps to identify pediatric muscle weakness and signs of neuromuscular disease.

How common is bowel cancer?

Preimplantation Genetic Diagnosis. Evaluation for single gene disorders

Child Abuse or Osteogenesis Imperfecta?

Cystic Fibrosis. Cystic fibrosis affects various systems in children and young adults, including the following:

3.5% 3.0% 3.0% 2.4% Prevalence 2.0% 1.5% 1.0% 0.5% 0.0%

Traumatic brain injury (TBI)

Understanding sport and physical activity as a therapy choice for young disabled people. Views and opinions of paediatric physiotherapists

Comprehensive Care for Duchenne Muscular Dystrophy

HYPERTROPHIC CARDIOMYOPATHY

UNIT 13 (OPTION) Genetic Abnormalities

Polymyalgia Rheumatica

A Guide to Prenatal Genetic Testing

Multifocal Motor Neuropathy. Jonathan Katz, MD Richard Lewis, MD

Muscular dystrophy: basic facts

95% of childhood kidney cancer cases are Wilms tumours. Childhood kidney cancer is extremely rare, with only 90 cases a year in

Electroconvulsive Therapy - ECT

Understanding Your Risk of Ovarian Cancer

Endoscopic Plantar Fasciotomy

GENERAL HEART DISEASE KNOW THE FACTS

Blood Pressure Assessment Program Screening Guidelines

The University of Hong Kong Department of Surgery Division of Esophageal and Upper Gastrointestinal Surgery

Transcription:

MANIFESTING CARRIERS OF DUCHENNE OR BECKER MUSCULAR DYSTROPHY Last updated April 2010 What is a Manifesting Carrier? A Manifesting Carrier is a female carrier of Duchenne or Becker Muscular (DMD or BMD) genetic mutation and displays symptoms of that muscle disorder. The severity can vary from mild generalised weakness to an inability to walk, differing from individual to individual. Only females can become Manifesting Carriers and onset of symptoms usually occurs between 16 to 48 years of age. It affects approximately 5-10% of all female carriers of DMD or BMD. What are the Features of Manifesting Carriers of Duchenne or Becker Muscular? Just as symptoms vary in DMD and BMD, there are a wide variety of presentations in Manifesting Carriers ranging from mild symptoms right through to a severe muscular dystrophy. There may be a slow progression of symptoms. The first symptoms tend to be aching muscles (myalgia) or cramps and are later accompanied by muscle weakness, most commonly affecting the upper arms and upper legs. A clumsiness or lack of co-ordination may be apparent, particularly in playing sport at school. Muscle weakness is not always symmetrical, and this can result in an unusual pattern of walking and a tendency to trip and fall. Individuals may experience exhaustion and difficulty rising from sitting or climbing stairs. Enlarged calf muscles are also common, known as pseudohypertrophy. Despite their appearance, these muscles are also weak. The heart muscle may also be affected, and this results in an abnormally fast heart rate (tachycardia). There may also be unexplained abdominal or chest pain. Intellectual ability may also be compromised to some degree. What Causes a Manifesting Carrier? DMD and BMD are both X-linked recessive disorders, and Manifesting Carriers arise in a few of the female carriers. One third of DMD and BMD cases are spontaneous, so it is possible to be a Manifesting Carrier without a family history. For further information on genetics and how disorders are inherited, please refer to the Genetics Factsheet. Additionally, the 1 of 4

Muscular Association Becker Muscular and Duchenne Muscular Factsheets give a more in depth look into these disorders. It is commonly believed that carriers merely pass on the disorder and are unaffected, however this is not always the case. Women have two X chromosomes and are often unaffected in X-linked disorders due to the ability of one X chromosome to mask the defect in the other. On rare occasions, a female may lack a second X chromosome entirely, or it may have been damaged during development and therefore is unable to mask the effects of DMD or BMD. Alternatively, via a mechanism called skewed X- inactivation, the body s cells rely on the X chromosome carrying the defect, so these females also develop the symptoms of DMD or BMD. In DMD and BMD, there is a defect on the dystrophin gene that results in faulty production of the dystrophin protein. This protein ordinarily aids in the stabilization of the muscle cell membrane. Without dystrophin, the muscle cells are prone to damage and leads to increased cell death. Eventually, degeneration occurs faster than muscle cell regeneration, leading to decreased muscle size and strength. Diagnosis of Manifesting Carriers of Duchenne or Becker Muscular Diagnosis usually commences after the identification of key early symptoms of Manifesting Carriers of DMD or BMD. Muscle Biopsy looks at individuals muscle cells for characteristic patterns of dystrophin Blood Testing look for non-random X-inactivation patterns and elevated levels of creatine phosphokinase (CPK) Electromyography (EMG) observes the electrical activity of muscles and its consistency with activity typical of Manifesting Carriers. Electrocardiogram (ECG) can identify abnormal heart rhythms DNA Testing can identify the presence of the abnormal gene in the individual 2 of 4

Individuals are sometimes misdiagnosed due to the similarity of symptoms in Manifesting Carriers to Limb Girdle Muscular. It is important to differentiate between the two. Soon after a diagnosis is made in the family, it is essential that genetic counselling is arranged. Genetic services in NZ are available and a referral can be made by the MDA. Management of Manifesting Carriers of Duchenne or Becker Muscular As there is currently no cure for DMD or BMD, treatment for Manifesting Carriers focuses on the prevention and management of symptoms. From an early stage, it is important to undergo regular exercise and stretching programmes, with the help of a physiotherapist, to maintain muscle strength and flexibility. Swimming is an excellent option to exercise and mobilize all muscles and joints. Resistance training has also been shown to be beneficial in decreasing falls and increasing strength. A good diet with plenty of fresh fruit and vegetables is very important in ensuring excessive weight does not impede mobility. Contact with a physician and/or a nutritionist is valuable for this. It is also helpful to have baseline and periodic evaluations on heart function to monitor any problems. Anaesthesia can be risky, and it is important that anaesthetists and surgeons are aware of the condition if surgery is necessary. Research on Duchenne Muscular and Becker Muscular Research is continuously being carried out and as more discoveries are made about the underlying causes of DMD and BMD, it will be possible to develop treatments aimed more directly at these causes, rather than simply towards the management of its symptoms. Research is looking into transferring new dystrophin genes to muscle cells and how to do so without causing an immune reaction. There are also studies looking at stem cells therapy, which replaces cells containing the defective gene with undifferentiated cells to regenerate muscle cells. Alternatively, experiments are researching how to use oligoribonucleotides to change the faulty genetic information and repair the mutation. Utrophin is a protein very similar to dystrophin, and individuals who maintain utrophin have less severe symptoms than those without it. It is 3 of 4

thought that this protein, if upregulated, could replace the function of dystrophin. Support for Manifesting Carriers of Duchenne or Becker Muscular Support is available from the MDA who can offer information, support, advocacy and referrals to other providers. There is also a nationwide Support Network for those interested in meeting with others. There is no reason why individuals with a diagnosis of Manifesting Carrier should be disadvantaged in terms of receiving full education. For more information, request the Education Pack available from the MDA. Disability should not hinder employment possibilities. Any individual has the right to equal pay and equal rights for employment. For more information contact the Employment Relations infoline on 0800 800 863 or visit www.ers.dol.govt.nz. The government promotes equal employment opportunities in private sector and can be contacted on (09) 525 3023 or visit www.eeotrust.org.nz Workbridge provides a professional employment service for people with all types of disabilities and administers support funding on behalf of Work and Income. Contact on 0508 858 858 or visit www.workbridge.co.nz More Information Muscular Association can be contacted for further information, assistance, advice, support and referrals, on 0800 800 337 or by e-mail at info@mda.org.nz. The Muscular Association Website also contains information on services available within NZ, contacts, membership details, news and links to other sites - www.mda.org.nz Further Resources www.nzord.org.nz the New Zealand Organisation for Rare Disorders website provides information on a number of rare disorders, a directory of support groups, practical advice, health and disability resources, research information, news and issues. www.mdausa.org the Muscular Association USA website has an extensive site with plenty of further information on any muscular dystrophy conditions as well as research news. www.dfsg.org.uk Duchenne Family Support Group is a UK website with further information on Manifesting Carriers and management. 4 of 4

Information in this fact sheet was primarily sourced from: Muscular Campaign (2004) Manifesting Carriers of Duchenne Muscular <www.muscular-dystrophy.org> Wikipedia (2006) Duchenne Muscular <http://en.wikipedia.org/wiki/duchenne_muscular _dystrophy> 5 of 4